Detalles de la búsqueda
1.
Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy.
Emerg Infect Dis
; 29(7): 1479-1481, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37253276
2.
Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting Antivirals.
Hepatology
; 68(3): 1010-1024, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29604220
3.
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma.
Liver Transpl
; 29(5): 559-563, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36747351
4.
Dynamic Angiopoietin-2 Serum Level as Endothelial Damage Marker and Potential Therapeutic Target.
Am J Pathol
; 192(9): 1336-1337, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36064255
5.
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies.
Liver Int
; 37(4): 514-528, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28105744
6.
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment.
Hepatol Res
; 46(11): 1074-1087, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26785389
7.
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
J Gastroenterol Hepatol
; 31(5): 936-44, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26667191
8.
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight.
Int J Mol Sci
; 17(3): 355, 2016 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27005620
9.
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD.
Liver Int
; 32(8): 1242-52, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22520641
10.
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma.
Oncol Lett
; 24(5): 395, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36276500
11.
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation.
Front Oncol
; 12: 960808, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36158651
12.
Gamma glutamyl transferase: A novel cardiovascular outfit for an old liver test.
Indian J Med Res
; 143(1): 4-7, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26997005
13.
Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease.
Diagnostics (Basel)
; 11(1)2021 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33435415
14.
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19.
Blood Adv
; 5(3): 662-673, 2021 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33560382
15.
Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent?
Liver Int
; 35(10): 2340-1, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25913160
16.
Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease?
Diseases
; 6(1)2018 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29462898
17.
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.
Adv Ther
; 34(6): 1291-1326, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28526997
18.
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases.
Metabolism
; 72: 57-65, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28641784
19.
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis.
World J Gastroenterol
; 23(8): 1458-1468, 2017 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28293093
20.
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens.
PLoS One
; 12(5): e0177352, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28545127